Ventripoint Diagnostics Announces Appointment of David Swetlow as Chief Financial Officer

Core Viewpoint - The appointment of David Swetlow as Chief Financial Officer (CFO) is a strategic move to strengthen Ventripoint's leadership team and support the global rollout of its AI-powered VMS+™ cardiac imaging platform [2][4][7]. Leadership Changes - David Swetlow, CPA, CA, iGP, has been appointed as CFO, effective immediately, marking a significant step in Ventripoint's transition into a growth phase [2][3]. - The company expresses gratitude to outgoing CFO Jimmy Jeon for his contributions during a critical transition period [5]. Strategic Focus - Swetlow's extensive experience in high-growth medical technology and life sciences will be crucial for Ventripoint as it aims to enhance its financial strategy, capital markets, and operational performance [3][6]. - The company is focused on executing a refreshed commercial strategy to scale its technology, strengthen global partnerships, and explore new markets for revenue growth [4][7]. Technology and Market Position - Ventripoint's VMS+™ technology platform is positioned as a leader in cardiac imaging innovation, utilizing AI to provide cost-effective and timely diagnostics for at-risk cardiac patients [7][9]. - The VMS products leverage proprietary Knowledge Based Reconstruction technology, offering accurate volumetric cardiac measurements comparable to MRI, thus enhancing cardiologists' confidence in patient management [9]. Compensation and Incentives - The Board of Directors has granted Mr. Swetlow 1,000,000 options exercisable at $0.11 with a term of 10 years, vesting over 12 months, aligning his interests with the company's growth objectives [8].